Market Overview:
The global cardiovascular device market size is expected to reach USD 106.54 billion by 2032, expected to grow at a CAGR of 8.1% during the forecast period.
Market Overview:
Polaris Market Research, a leading market research firm, has recently released its latest update on Cardiovascular Device Market. The research report provides an extensive outlook of the industry, covering future trends, growth trends, and industry-valued market forecasts. It offers a thorough analysis of the Cardiovascular Device Market share, size, dynamics, country-level, and projection outlook. Also, the research report covers segmental analysis and offers extensive information about growth prospects and the technological landscape for the market.
The research report traces major trends shaping the future growth landscape of the market. Along with all the major growth drivers, the study sheds light on the industry restraints and challenges that may impede the Cardiovascular Device Market growth. It covers the current industry developments, offering an analysis of how activities such as partnerships, product launches, and mergers shape the industry’s prospects. Furthermore, several industry facets are presented in the report by identifying the major market influencers.
Download Free Sample PDF Copy of the Report:
Some of the Cardiovascular Device Market key players are:
- Abbott Laboratories
- B. Braun Melsungen AG
- Biosensors International Group (acquired by Blue Sail Medical Co., Ltd)
- Biotronik SE & Co.KG
- Boston Scientific Corporation
- C. R. Bard, Inc.
- Cook Medicals
- Lepu Medicals
- Liaoning Biomedical Materials
- Medtronic Plc
- Meril Life Sciences
- MicroPort Scientific Corporation
- Terumo Corporation
- Translumina GmbH
- Vascular Concepts
- Jude Medical, Inc.
- Edward lifesciences corporation
Key Findings of the Report:
- The research report offers a detailed industry analysis showcasing product/service consumption across various regions.
- The study identifies the major elements influencing the Cardiovascular Device Market in each area.
- The report analyzes the regions and industries with the highest growth potential.
- Outlines the global potential and risks industry participants might encounter.
- The study details the introduction of new products/services, corporate growth, and major acquisitions.
- The research includes corporate insights, business overviews, and SWOT analysis for every major industry segment.
- The study highlights the current industry developments and geographical constraints present in developed regions worldwide.
Segmental Overview:
The market report categorizes the industry into various segments based on common characteristics. The Cardiovascular Device Market segmentation is primarily based on type, application, end use, and region. The segmental analysis is aimed at helping businesses, and stakeholders determine the characteristics their products or services should have in order to meet market expectations. Also, it helps businesses better understand consumer buying behavior and patterns for the consumer-based market. Besides, a thorough analysis of various industry sub-segments has been provided in the report. Our team of expert analysts ensures that the research study is segmented with accurate sales and marketing channels to identify the prospective market size by volume and revenue.
Cardiovascular Devices Market, Device Type Outlook (Revenue – USD Billion, 2019-2032)
- Diagnostic And Monitoring Devices
- Electrocardiogram
- Remote Cardiac Monitoring
- MRI
- Others
- Therapeutic And Surgical Devices
- Ventricular Assist Devices
- Cardiac Rhythm Management Devices
- Catheter
- Stents
- Others
Cardiovascular Devices Market, Application Outlook (Revenue – USD Billion, 2019-2032)
- Heart Failure
- Cardiac Arrhythmia
- Coronary Artery Disease
- Others
Cardiovascular Devices Market, End-Use Outlook (Revenue – USD Billion, 2019-2032)
- Hospitals
- Surgical Centers
- Cardiology Centers
- Specialty Clinics
Competitive Landscape:
The research report offers a detailed analysis of Cardiovascular Device Market key players. It assesses the product and service industry segmentation, industry share, revenue, product portfolios, geographical footprints, and operating strategies. The study helps businesses comprehend their unique position in the dynamically evolving market. Besides, gross margin analysis, sales information, and price patterns concerning each major industry participant have been provided in the study. The study includes a SWOT analysis and Porter’s Five Forces analysis to analyze the industry’s competitive forces.
Recent Developments in Cardiovascular Technology:
- Abbott Launches Ultreon 1.0 Software (April 2021):
Abbott unveiled the Ultreon 1.0 Software, an AI-powered platform for coronary imaging. This software aims to improve the identification of calcium-based blockages and offer precise measurements of channel diameters during coronary stenting procedures. The software made its debut in Europe as part of Abbott’s continued efforts to advance cardiovascular diagnostics. - Cardiovascular Systems Inc. Partners with Chansu Vascular Technologies (February 2021):
Cardiovascular Systems Inc. announced a strategic collaboration with Chansu Vascular Technologies to develop drug-coated balloons for use in peripheral and coronary applications. This partnership combines both companies’ expertise to enhance interventional cardiology and improve treatment options for patients with cardiovascular conditions. - Edward Life Sciences Receives Chinese Approval for SAPIEN 3 Transcatheter Heart Valve (2020):
Edward Life Sciences Corporation obtained Chinese regulatory approval for the SAPIEN 3 transcatheter heart valve. This device is designed for patients with severe symptomatic aortic stenosis, offering a less invasive option compared to traditional open-heart surgery.
Medical devices used in the treatment of heart disease or cardiovascular disorder are known as cardiovascular devices. Changing lifestyles, increasing alcohol intake in adults, passive smoking and other factors are increasing the risk of various diseases in the upcoming population. Heart failure has been the most common among the veteran population globally.